Modeling and validation of L-asparaginase enzyme, an anticancer agent using the tools of computational biology

Praveen Reddy P.


Background: The L-Asparaginase is a medically important drug. The L-Asparaginase enzyme, an anticancer agent produced by microorganisms is used for the treatment of patients suffering from lymphoma and leukemia. The L-Asparaginase is economical and its administration is easy when compared to other commercial drugs available in market. Many microbes have been reported to produce the L-Asparaginase.

Methods: In the present work the sequence of L-Asparaginase enzyme protein was obtained from the Universal Protein Resource (UNIPROT) server. The sequence of L-Asparaginase was used to generate 3-D model of L-Asparaginase in SWISS MODEL server. The constructed L-Asparaginase model was verified using Ramachandran Plot in PROCHECK server.

Results: The FASTA format of L-Asparaginase enzyme of Bacillus subtilis strain 168 was retrieved from UNIPROT server. The FASTA format of L-Asparaginase was submitted to SWISS MODEL and its three-dimensional structural model was developed based on relevant template model. The model structure of L-Asparaginase was validated in PROCHECK server using Ramachandran Plot. The Ramachandran Plot of L-Asparaginase model inferred the reliability of L-Asparaginase structure model developed in SWISS MODEL server.  

Conclusions: In the present study computational tools were exploited to develop and validate a potent anticancer drug, L-Asparaginase. Further the modeled L-Asparaginase enzyme protein can be improved using advanced bioinformatics tools and the same improved enzyme can be produced by improving the L-Asparaginase producing microbial strains by site-directed mutagenesis in the corresponding gene.


Anticancer, L-Asparaginase, PROCHECK server, SWISS MODEL server, Universal protein resource server

Full Text:



Mangamuri U, Vijayalakshmi M, Ganduri VS, Rajulapati SB, Poda S. Extracellular L-Asparaginase from Streptomyces labedae VSM-6: Isolation, Production and Optimization of Culture Conditions Using RSM. Pharmacog J. 2017;9(6).

Kamble KD, Bidwe PR, Muley VY, Kamble LH, Bhadange DG, Musaddiq M. Characterization of l-asparaginase producing bacteria from water, farm and saline soil. Biosci Discov. 2012;3(1):116-9.

Yogendra S, Srivastava SK. Isolation and Characterization of Microorganisms capable of producing antineoplastic drug, L-asparaginase. International J Biol Med Res. 2012;3:2548-54.

Bhat MR, Nair JS, Marar T. Isolation and identification of l-asparaginase producing Salinicoccus sp. M KJ997975 from soil microbial flora. Intern J Pharmaceutical Sci Res. 2015;6(8):3599.

Jaya Kumar A, Balakrishna Pillai A, Kumarapillai H. Sequencing and characterization of L-asparaginase (ansB) gene of Bacillus megaterium isolated from Western Ghats, Kerala, India. Intern J Current Microbiol Applied Sci. 2015;4(6):753-60.

Apweiler R, Bairoch A, Wu CH, Barker WC, Boeckmann B, Ferro S, et al. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 2004;32(1):D115-9.

Arnold K, Bordoli L, Kopp J, Schwede T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics. 2006;22(2):195-201.

Balaji S, Kalpana R, Shapshak P. Paradigm development: comparative and predictive 3D modeling of HIV-1 Virion Infectivity Factor (Vif). Bioinformation. 2006;1(8):290.

Yun MK, Nourse A, White SW, Rock CO, Heath RJ. Crystal structure and allosteric regulation of the cytoplasmic Escherichia colil-asparaginase I. J Mole Biol. 2007;369(3):794-811.

Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46(W1):W296-303.

Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J Applied Crystallo. 1993;26(2):283-91.